Abstract: A system for reducing a specific absorption rate includes a source field generation unit wound with a first cylindrical coil and accommodating a source material therein, and generating a source field by applying a periodic input signal to the first cylindrical coil; a physical property change unit wound with a second cylindrical coil disposed adjacent to the first cylindrical coil and accommodating a transfer target therein, and changing a physical property of the transfer target based on the generated source field; and a target field circuit unit controlling the transfer target to form a target field by a PCB substrate with a power supply interface connected to a power supply and an input of the power supply.

Abstract: New platinum(IV) complexes which has a strong antitumor activity and has a feature that a side effect is relatively reduced is provided. The new complex is platinum(IV) complexes with cis,cis-spiro[4,4]nonane-1,6-diamine ligand and is platinum(IV) complexes with optically active cis,cis-spiro[4,4]nonane-1,6-diamine ligand. Especially, the new complex is dichloromalonato((1S,5S,6S)-spiro[4.4]nonane-1,6-diamine)platinum(IV).

Abstract: A new platinum complex which has strong antitumor activity and has effect with smaller doses and a pharmaceutical composition containing the same are provided. A spiro[4,4]nonane-1,6-diamineplatinum(II) complex which is represented by a following general formula (A). (In the formula, X and Y are same or different, and X and Y represent halogen atoms respectively, or X and Y cooperatively represent a divalent residue which is described by a formula (Z).) The platinum complex has a strong antitumor activity and is efficacious as a therapeutic agent for malignant tumors.

Abstract: A new platinum complex which has strong antitumor activity and has effect with smaller doses and a pharmaceutical composition containing the same are provided. A spiro[4,4]nonane-1,6-diamineplatinum(II) complex which is represented by a following general formula (A). (In the formula, X and Y are same or different, and X and Y represent halogen atoms respectively, or X and Y cooperatively represent a divalent residue which is described by a formula (Z).) The platinum complex has a strong antitumor activity and is efficacious as a therapeutic agent for malignant tumors.

Abstract: The present invention has completely broken from the unreasonable construction of conventional type of relief valve which places weight and lifting disc inside of upper body or lower body. In other words, lifting disc and weight are placed outside of upper body. It is brand-new construction that adopts casket-shaped housing forming flow slot which guides releasing gas to move upwards vertically when the above-mentioned lifting disc ascends by the releasing gas from tank. And also the present invention features that drain part is formed to drain all the time sea water or rain gathering inside of casket-shaped housing to outside of casket-shaped housing and brand-new construction of vacuum relief valve is equipped.

Abstract: The present invention relates to a process for preparing silica microcapsules and more particularly, to a process for preparing silica microcapsules comprising the steps of dissolving tetraethyl orthosilicate (TEOS) into an aqueous solution containing a hydrolysis catalyst to control a degree of hydrolysis and contribute hydrophilicity or lipophilicity, adding a core material and an appropriate amount of aminopropyltrialkoxysilane(APS) as a gelling agent into the solution, and emulsifying and dispersing the resulting solution to a solution having a polarity opposite to that of the core material to microcapsulate by coating the core material with silica shell via a sol-gel reaction. The process for preparing microcapsules of the present invention reduces environmental pollution compared to conventional processes using an alkali gelling agent such as an ammonia solution, and are suitable for both organic or inorganic core materials having hydrophilic or lipophilic property.

Abstract: The present invention provides a method of detecting RNA, comprising: (a) preparing cDNA to be measured and standard cDNA by reverse transcription of RNA as the subject of detection and standard RNA respectively; (b) adding different adapters respectively to the standard cDNA prepared at stepwise concentrations; (c) adding an adapter other than said adapters to the cDNA to be measured; (d) mixing and amplifying the adapter-tagged cDNAs obtained in the steps (b) and (c); (e) measuring the amount ratio of the cDNA measured to the standard cDNA; and (f) detecting said RNA from the measurement results.